title: [Treatment of thrombotic thrombocytopenic purpura].
authors.forename: Yasunori
authors.initials: Y
authors.lastname: Ueda
mesh_terms: D051722:ADAM Proteins / Q000008:administration & dosage / Q000235:genetics; D000071120:ADAMTS13 Protein; D058846:Antibodies, Monoclonal, Murine-Derived / Q000008:administration & dosage; D000925:Anticoagulants / Q000008:administration & dosage; D052157:Aptamers, Nucleotide / Q000008:administration & dosage; D002406:Catheterization, Peripheral; D003520:Cyclophosphamide / Q000008:administration & dosage; D004359:Drug Therapy, Combination; D015316:Genetic Therapy; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage; D010949:Plasma; D010951:Plasma Exchange / Q000379:methods; D017713:Platelet Transfusion; D011239:Prednisolone / Q000008:administration & dosage; D011697:Purpura, Thrombotic Thrombocytopenic / Q000175:diagnosis / Q000209:etiology / Q000235:genetics / Q000628:therapy*; D011994:Recombinant Proteins / Q000008:administration & dosage; D000069283:Rituximab; D061905:Single-Domain Antibodies / Q000008:administration & dosage; D014841:von Willebrand Factor
chemical_list: C526287:ARC 1779; D058846:Antibodies, Monoclonal, Murine-Derived; D000925:Anticoagulants; D052157:Aptamers, Nucleotide; D007166:Immunosuppressive Agents; D011994:Recombinant Proteins; D061905:Single-Domain Antibodies; D014841:von Willebrand Factor; C585343:caplacizumab; D000069283:Rituximab; D003520:Cyclophosphamide; D011239:Prednisolone; D051722:ADAM Proteins; D000071120:ADAMTS13 Protein; C099604:ADAMTS13 protein, human